Revvity, Inc. (RVTY)
152.64
-2.07
(-1.34%)
USD |
NYSE |
Oct 16, 16:00
151.94
-0.70
(-0.46%)
After-Hours: 20:00
Revvity Cash from Investing (Quarterly) : -3.505M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.505M |
| March 31, 2026 | -78.27M |
| December 31, 2025 | -20.45M |
| September 30, 2025 | 18.97M |
| June 30, 2025 | -9.493M |
| March 31, 2025 | -6.378M |
| December 31, 2024 | -17.33M |
| September 30, 2024 | 690.18M |
| June 30, 2024 | 121.49M |
| March 31, 2024 | -18.18M |
| December 31, 2023 | -414.81M |
| September 30, 2023 | 434.87M |
| June 30, 2023 | -571.04M |
| March 31, 2023 | 1.865B |
| December 31, 2022 | -25.68M |
| September 30, 2022 | -22.51M |
| June 30, 2022 | -28.36M |
| March 31, 2022 | -56.31M |
| December 31, 2021 | -59.95M |
| September 30, 2021 | -3.301B |
| June 30, 2021 | -290.02M |
| March 31, 2021 | -461.85M |
| December 31, 2020 | -436.40M |
| September 30, 2020 | -22.52M |
| June 30, 2020 | -23.56M |
| Date | Value |
|---|---|
| March 31, 2020 | -22.01M |
| December 31, 2019 | -172.03M |
| September 30, 2019 | -29.02M |
| June 30, 2019 | -257.29M |
| March 31, 2019 | -29.23M |
| December 31, 2018 | -87.96M |
| September 30, 2018 | 8.019M |
| June 30, 2018 | -56.25M |
| March 31, 2018 | -23.67M |
| December 31, 2017 | -1.454B |
| September 30, 2017 | 45.33M |
| June 30, 2017 | 271.82M |
| March 31, 2017 | -129.84M |
| December 31, 2016 | -22.65M |
| September 30, 2016 | -70.43M |
| June 30, 2016 | 9.532M |
| March 31, 2016 | -17.29M |
| December 31, 2015 | -65.12M |
| September 30, 2015 | -6.958M |
| June 30, 2015 | -19.74M |
| March 31, 2015 | -9.039M |
| December 31, 2014 | -272.08M |
| September 30, 2014 | -9.231M |
| June 30, 2014 | -8.565M |
| March 31, 2014 | -6.02M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 164.00M |
| Danaher Corp. | -10.15B |
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -66.70M |
| Bruker Corp. | -25.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 191.94M |
| Cash from Financing (Quarterly) | -23.16M |
| Free Cash Flow | 558.11M |
| Free Cash Flow Per Share (Quarterly) | 1.620 |
| Free Cash Flow to Equity (Quarterly) | 189.53M |
| Free Cash Flow to Firm (Quarterly) | 200.22M |
| Free Cash Flow Yield | 3.23% |